Published in Anticancer Res on June 01, 2010
Biomarkers in cancer: is 'omices' the way to go. Libyan J Med (2011) 0.75
Oral mucosa as a reservoir of human papillomavirus: point prevalence, genotype distribution, and incident infections among males in a 7-year prospective study. Eur Urol (2012) 3.38
Steroid-resistant nephrotic syndrome: impact of genetic testing. Ann Saudi Med (2014) 2.02
Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancer. Acta Cytol (2006) 1.42
More comprehensive forensic genetic marker analyses for accurate human remains identification using massively parallel DNA sequencing. BMC Genomics (2016) 1.39
Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study. Int J Cancer (2010) 1.34
Primary large cell neuroendocrine carcinoma of the urinary bladder. Arch Pathol Lab Med (2002) 1.28
Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Hum Pathol (2008) 1.25
Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints. Anticancer Res (2005) 1.25
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis. Anticancer Res (2014) 1.17
Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear. Gynecol Oncol (2005) 1.14
Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma. Oncogene (2003) 1.11
Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients. Parkinsonism Relat Disord (2008) 1.10
VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival. Anticancer Res (2009) 1.06
Diagnosis delay in Libyan female breast cancer. BMC Res Notes (2012) 1.05
MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients. Cancer Invest (2010) 1.04
Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factors. BMC Res Notes (2009) 1.03
Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecol Oncol (2003) 1.02
Oxidative stress and hepatitis C virus. Virol J (2013) 1.02
Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis. Anticancer Res (2009) 1.01
Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy. J Gen Virol (2009) 1.01
Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins. Infect Agent Cancer (2006) 0.99
Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma. Anticancer Res (2011) 0.99
Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection. Scand J Infect Dis (2008) 0.98
Hepatic-associated immunoglobulin-A nephropathy in a child with liver cirrhosis and portal hypertension. Saudi J Gastroenterol (2012) 0.95
Comparison of DNA sequencing and Roche Linear array in human papillomavirus (HPV) genotyping. Anticancer Res (2006) 0.94
Increased risk of oncogenic human papillomavirus infections and incident high-grade cervical intraepithelial neoplasia among smokers: experience from the Latin American screening study. Sex Transm Dis (2009) 0.94
Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus. Int J Gynecol Pathol (2005) 0.94
Detection of oncogenic DNA viruses in colorectal cancer. Anticancer Res (2008) 0.93
Breast cancer patients in Libya: Comparison with European and central African patients. Oncol Lett (2011) 0.93
Human papillomavirus genotypes present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus genotypes. J Pediatr (2011) 0.93
Interdigitating dendritic cell sarcoma of the duodenum with rapidly fatal course: a case report and review of the literature. Arch Pathol Lab Med (2006) 0.92
Nuclear morphometry in FNABs of breast disease in Libyans. Anticancer Res (2009) 0.92
Detection and expression of human papillomavirus oncogenes in non-small cell lung cancer. Oncol Rep (2006) 0.92
BRAF mutations in thyroid tumors from an ethnically diverse group. Hered Cancer Clin Pract (2012) 0.92
ABO-incompatible liver transplantation for critically ill adult patients. Transpl Int (2007) 0.91
Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study). Gynecol Oncol (2012) 0.91
Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes. Scand J Infect Dis (2010) 0.90
Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol (2005) 0.90
Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer. Am J Clin Pathol (2004) 0.90
HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas. J Clin Virol (2011) 0.90
Tobacco smoking and chewing as risk factors for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Côte d'Ivoire and Finland) with different tobacco exposure. Cancer Causes Control (2008) 0.90
Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways. Intervirology (2008) 0.89
Hormonal contraceptives and the length of their use are not independent risk factors for high-risk HPV infections or high-grade CIN. Gynecol Obstet Invest (2010) 0.89
Methylation of the polycomb group target genes is a possible biomarker for favorable prognosis in colorectal cancer. Cancer Epidemiol Biomarkers Prev (2012) 0.89
Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the Former Soviet Union. J Clin Microbiol (2004) 0.89
Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines. Vaccine (2012) 0.88
Immunohistochemically detectable bcl-2 expression in metastatic melanoma: association with survival and treatment response. Oncology (2002) 0.88
RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency. Anticancer Res (2011) 0.88
Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: a six-year follow-up study. PLoS One (2013) 0.87
Prognostic value of proliferation markers: immunohistochemical ki-67 expression and cytometric s-phase fraction of women with breast cancer in libya. J Cancer (2012) 0.87
Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma. APMIS (2012) 0.87
High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer. Anticancer Res (2013) 0.87
Individualized medicine enabled by genomics in Saudi Arabia. BMC Med Genomics (2015) 0.87
Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array tests. Sex Transm Dis (2008) 0.87
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma. J Gastrointest Cancer (2009) 0.86
Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma. Melanoma Res (2008) 0.86
P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear. Acta Cytol (2007) 0.86
Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population. Anticancer Res (2013) 0.85
Evaluation of HER-2/neu gene amplification by fluorescence in situ hybridization and immunohistochemistry in saudi female breast cancer. Anticancer Res (2010) 0.85
Apoptosis in breast cancer: Nigerian vs. Finnish material. Anal Quant Cytol Histol (2002) 0.84
Sexual habits and human papillomavirus infection among females in three New Independent States of the former Soviet Union. Sex Transm Dis (2003) 0.84
Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma. World J Gastroenterol (2012) 0.84
Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology. Virchows Arch (2012) 0.84
Applicability of liquid-based cytology to the assessment of DNA content in cervical lesions using static cytometry. Anal Quant Cytol Histol (2003) 0.84
Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study. PLoS One (2012) 0.84
Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma. Tumour Biol (2012) 0.84
Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort. Virchows Arch (2009) 0.84
Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers. Anticancer Res (2013) 0.83
High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast. Tumour Biol (2013) 0.83
Smoking worsens the prognosis of mild abnormalities in cervical cytology. Acta Obstet Gynecol Scand (2009) 0.83
Discrepancies in expression and prognostic value of tumor markers in adenocarcinoma and squamous cell carcinoma in cervical cancer. Anticancer Res (2009) 0.83
Outcome of conservatively treated microinvasive squamous cell carcinoma of the uterine cervix during a 10-year follow-up. Int J Gynecol Cancer (2009) 0.83
MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases. Scand J Gastroenterol (2007) 0.83
IgA nephropathy: a clinicopathologic study from two centers in Saudi Arabia. Saudi J Kidney Dis Transpl (2010) 0.82
Prognostic value of necrosis in Nigerian breast cancer. Adv Clin Path (2002) 0.82
Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder. Libyan J Med (2012) 0.82
Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: an analysis of 166 cases. Gynecol Oncol (2011) 0.82